Posts

Short Bowel Syndrome Market is estimated to be US$ 2644.94 million by 2030 with a CAGR of 15.4% during the forecast period

Image
  Short Bowel Syndrome  affect the useful capability of gut. Patients laid low with short bowel syndrome have a discounted capability to take in trace factors, fats, vitamins, fluids, minerals and carbohydrates and might experience weight loss, malnutrition, diarrhea and dehydration. Presently, there is no cure for quick bowel syndrome and the treatment is targeted toward signs. In a few cases, brief bowel syndrome can be life-threatening however usually, the disorder can be controlled via effective remedy. Region Analysis: The global short bowel syndrome remedy market may be segmented into the following regions – North America, Latin America, Europe, Asia Pacific and the Middle East & Africa. North America dominates the global short bowel syndrome remedy market, specifically due to the sturdy healthcare gadget and compensation regulations in the location. North America, particularly the U.S., is a dominant region inside the market, due to excessive adoption among ce...

Molecular Imaging Market is estimated to be US$ 13.7 Billion by 2029 with a CAGR of 7.3% during the forecasted period.

Image
  Molecular Imaging is a discipline that integrates molecular biology, cell biology, and diagnostic imaging, which is used for various clinical application that include the use of nuclear medicine, magnetic resonance imaging and ultrasound.  The molecular imaging has two basic applications, first is diagnostic imaging used to determine the location and extent of targeted molecules specific to the disease and second is a therapy used to treat specific disease-targeted molecules. Also, it has the potential to have a significant influence on healthcare sector by early diagnosis, evaluating disease severity, and use of personalized treatment. The global molecular imaging market accounted for US$ 6.8 billion in 2019 and is estimated to be US$ 13.7 billion by 2029 and is anticipated to register a CAGR of 7.3%. The report  " Global   Molecular Imaging Market, By Technology (Gamma Camera, SPECT, PET, Magnetic Resonance Spectroscopy, Optical Imaging, and Molecular Ultrasou...

Nephrology and Urology Devices Market is estimated to be US$ 8.98 billion by 2030 with a CAGR of 6.7% during the forecast period 2030

Image
  Nephrology And Urology Devices includes, stone basket, renal dilators, PCN catheters, urology guidewires, ureteral catheters and urinary sents. Main types of nephrology and urology devices are dialysis equipment, endoscopy devices, urinary stone treatment devices. Nephrology and Urology devices are used in treatment of chronic diseases like kidney stone, kidney diseases, urinary incontinence, urinary system. Dialyzer is the equipment used in dialysis. Hemodialysis, Continuous renal replacement therapy, Peritoneal dialysis are the different types of dialysis. Low-flux, High-flux and Protein leaking are the different types of dialyzer. Dialysis is used for filtration of blood. Rising prevalence of chronic diseases like kidney disease, urine disorder has favored the growth of the market. Rising awareness of newly advanced devices which are helpful in treatment has driven the major factor in nephrology and urology devices market growth. Growth in population has also increased the ri...

Mesenchymal Stem Cells Market is estimated to be US$ 9.17 billion by 2032 with a CAGR of 12.8% during the forecast period

Image
Mesenchymal Stem Cells Market accounted for US$ 2.8 billion in 2020 and is estimated to be US$ 9.17 billion by 2030 and is anticipated to register a CAGR of 12.8%. Mesenchymal stem cells is also called as mesenchymal stromal cells or medicinal signaling cells. Mesenchymal stem cells are that have the ability to self-renew and also show multilineage differentiation. Mesenchymal stem cells can be isolated from a various type of tissues, such as umbilical cord, endometrial polyps, menses blood, bone marrow etc. Recently, many Mesenchyamal stem cells is obtained from menstrual blood and endometrium, its new sources of mesenchyamal stem cells. Mesenchymal stem cells have been used to treat stroke in animal models and are modified by a mechanism that does not appear to involve cell replacement. This discovery increases hope that menstrual stem cells are not only myogenic but also neurogenic and may be used in stroke therapy in the future, in upcoming years, the evolution of stem cell therap...